Business Context and Reporting Period
Myomo, Inc., a Delaware corporation and emerging growth company, filed this Form 8-K on December 13, 2017. The report addresses a specific corporate event occurring on the same date regarding the termination of a material definitive agreement.
Key Financial Metrics
This filing does not provide comprehensive financial statements, revenue, profit, or cash flow data. The only specific financial metric disclosed is the repayment of debt:
- Debt Repayment: Approximately $874,600.58.
- Components: Included all outstanding principal and accrued but unpaid interest.
- Creditor: Massachusetts Life Sciences Center (MLSC).
Material Changes
The primary material change reported is the full satisfaction of obligations under the Funding Agreements and associated promissory notes originally dated June 7, 2011, and August 22, 2011. These agreements had been amended multiple times, with the final amendments occurring in May and June 2017. The repayment on December 13, 2017, terminated these agreements entirely.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or discussion of risks and contingencies beyond the specific event of debt repayment. No unusual items were reported.
Investor Verification Checklist
- Verify the impact of the $874,600.58 cash outflow on the company's current liquidity position.
- Confirm the removal of the MLSC debt obligation from the company's balance sheet in subsequent filings.
- Review the terms of the original 2011 Funding Agreement and subsequent amendments to understand the interest rate history and repayment schedule.